scispace - formally typeset
A

Alexandra Giatromanolaki

Researcher at Democritus University of Thrace

Publications -  360
Citations -  26647

Alexandra Giatromanolaki is an academic researcher from Democritus University of Thrace. The author has contributed to research in topics: Angiogenesis & Cancer. The author has an hindex of 66, co-authored 340 publications receiving 22956 citations. Previous affiliations of Alexandra Giatromanolaki include John Radcliffe Hospital.

Papers
More filters
Journal Article

Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.

TL;DR: The development of novel monoclonal antibodies recognising specifically the mutated versus the wild type form of proteins would apparently improve the prognostic and predictive value of the immunohistochemically detected apoptotic proteins.
Journal ArticleDOI

Autophagy and Bcl‐2/BNIP3 death regulatory pathway in non‐small cell lung carcinomas

TL;DR: The accelerated autophagic status in NSCLC is unrelated to Beclin 1 and BNIP3 expression, but does show significant association with Bcl‐2 reactivity, and important correlations between glucolysis and autophagy are shown, guiding new pathways in future lung carcinoma research.
Journal ArticleDOI

Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation.

TL;DR: It is concluded that intense neo-angiogene-sis in locally advanced squamous cell head neck cancer is a frequent event, which is associated with nuclear p53 accumulation and thymidine phosphorylase overexpression.
Journal ArticleDOI

Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1α

TL;DR: Since it is doubtful whether dephosphorylation of amifostine to the active metabolite WR-1065 occurs within tumoral tissues (an acidic environment that lacks vascular alkaline phosphatase activity), intracellular hypoxia and upregulation of HIF1α represents an additional, normal tissue-specific, am ifostine cytoprotective pathway.